Back to Authors

Nicoloso, Milena S.

https://orcid.org/0000-0003-4231-9303

Mayo Clinic

Mayo Clinic

Citations 1

MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer
Nicoloso, Milena S. , Arvizo, Rochelle R., Wang, Enfeng , Cortez, Angelica, Calin, George A. , Bhattacharya, Resham , Rossi, Simona , Mukherjee, Priyabrata

Cancer Research | November 10, 2009 | Volume: 69 | Issue: 23 | Pages: 9090-9095

10.1158/0008-5472.can-09-2552 Get It

Abstract Oncogenic activation of Bmi-1 is found in a wide variety of epithelial malignancies including ovarian cancer, yet a specific mechanism for overexpression of Bmi-1 has not been determined. Thus, realizing the immense pathologic significance of Bmi-1 in cancer, we wanted to investigate if microRNA (miRNA) aberrations played a role in the regulation of Bmi-1 in ovarian cancer. In this report, we identify two miRNAs, miR-15a and miR-16, that are underexpressed in ovarian cell lines and in primary ovarian tissues. We show that these miRNAs directly target the Bmi-1 3′ untranslated region and significantly correlate with Bmi-1 protein levels in ovarian cancer patients and cell lines. Furthermore, Bmi-1 protein levels are downregulated in response to miR-15a or miR-16 expression and lead to significant reduction in ovarian cancer cell proliferation and clonal growth. These findings suggest the development of therapeutic strategies by restoring miR-15a and miR-16 expression in ovarian cancer and in other cancers that involve upregulation of Bmi-1. [Cancer Res 2009;69(23):9090–5]